BMJ  2007;334:1175-1176 (9 June), doi:10.1136/bmj.39065.460208.80

Editorials

Treatment of epilepsy in developing countries

Cheap and effective drugs exist but are not accessible to most patients

The first 150 words of the full text of this article appear below.

Of the 35 million people with epilepsy who live in developing countries, around 85% receive no treatment at all.^{1 2} As a consequence, they experience morbidity related to seizures and the psychosocial consequences of stigma and discrimination. Regrettably, most of these people—many of whom are children—could have their seizures completely controlled and they could return to a normal life by taking a single daily dose of a drug that costs less than $3 (£1.50; 2.20) each year.³ In this week's BMJ, a randomised controlled trial in Bangladesh by Banu and colleagues compares the effects of carbamazepine and phenobarbital on seizure control and behavioural side effects in 108 children with epilepsy.⁴

The World Health Organization recommends phenobarbital as the treatment of choice for partial and tonic clonic seizures in resource restricted countries,⁵ but this policy has been questioned because phenobarbital is thought to be less well tolerated than other antiepileptic drugs.⁶ . . . [Full text of this article]

Clinical Pharmacology Unit, Institute of Neurology, IRCCS C Mondino Foundation, University of Pavia, I-27100 Pavia, Italy

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

About children . . . and more

Rajendra Kale
BMJ 2007 334: 0. [Extract] [Full Text]

Morals and ethics and medicine

Douglas Kamerow
BMJ 2007 334: 0. [Extract] [Full Text]

Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial

Selina H Banu, Moshrat Jahan, Umme Kulsum Koli, Saadia Ferdousi, Naila Z Khan, and Brian Neville
BMJ 2007 334: 1207. [Abstract] [Full Text] [PDF]